Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $50+, returning 11,232.3%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 11,232.34% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 7,651.94% |
Diginex Limited Ordinary Shares (DGNX) | 2,378.87% |
DeFi Development (DFDV) | 2,120.24% |
WW International, Inc Common Stock (WW) | 2,047.33% |
Zepp Health (ZEPP) | 1,676.15% |
Abits (ABTS) | 1,224.45% |
FiEE (FIEE) | 1,184.4% |
Oncology Institute (TOI) | 1,050.33% |
Abivax SA American Depositary Shares (ABVX) | 1,032.6% |
Global Interactive Technologies (GITS) | 904.15% |
Lizhi (SOGP) | 828.7% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 725.45% |
Nova Lifestyle I (NVFY) | 668.53% |
Lixte Biotechnology (LIXTW) | 657.14% |
Dominari (DOMH) | 639.56% |
Airnet Technology (ANTE) | 627.88% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 580.99% |
Mobilicom Limited Warrants (MOBBW) | 559.99% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 555.14% |
mF International Limited Ordinary Shares (MFI) | 550.08% |
ThredUp (TDUP) | 546.53% |
Eightco (OCTO) | 514.9% |
Better Home & Finance (BETR) | 511.36% |
Forward Industries (FORD) | 489.37% |
